Search research articles
Contact Us
Filters
Showing results (151-160 of 166) with videos related to
Page
of 17
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2015
BRAF codons 594 and 596 mutations identify a new molecular subtype of metastatic colorectal cancer at favorable prognosis
C Cremolini, M Di Bartolomeo, A Amatu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 2, 2006
Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe
L Barkholt, M Bregni, M Remberger, et al.
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia
|
August 6, 2010
[Algorithm for assessment of exposure to asbestos]
V Martines, M Fioravanti, A Anselmi, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Patient-Reported Experience Measures (PREMs) in patients with metastatic colorectal cancer undergoing treatment supported by feedback auditing: the EPIC study
A Sartore-Bianchi, F Toscano, D P Bernasconi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 22, 2002
Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD)
S Cascinu, F Graziano, F Ferraù, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 27, 2016
Tumor MGMT promoter hypermethylation changes over time limit temozolomide efficacy in a phase II trial for metastatic colorectal cancer
A Amatu, L Barault, C Moutinho, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2014
Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer
J Y Douillard, S Siena, J Cassidy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 27, 2015
Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer
L Barault, A Amatu, F E Bleeker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 26, 2014
High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors: mature results of an Italian randomized phase II study
A Necchi, L Mariani, M Di Nicola, et al.
ESMO Open
|
July 16, 2025
Prognostic impact and clinical management of pT4N0 colon cancer: data from a large, multicenter, international, real-world dataset
V Daprà, A Gandini, F Schietroma, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 166) with videos related to
Sort By:
Page
of 17
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2015
BRAF codons 594 and 596 mutations identify a new molecular subtype of metastatic colorectal cancer at favorable prognosis
C Cremolini, M Di Bartolomeo, A Amatu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 2, 2006
Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe
L Barkholt, M Bregni, M Remberger, et al.
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia
|
August 6, 2010
[Algorithm for assessment of exposure to asbestos]
V Martines, M Fioravanti, A Anselmi, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Patient-Reported Experience Measures (PREMs) in patients with metastatic colorectal cancer undergoing treatment supported by feedback auditing: the EPIC study
A Sartore-Bianchi, F Toscano, D P Bernasconi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 22, 2002
Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD)
S Cascinu, F Graziano, F Ferraù, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 27, 2016
Tumor MGMT promoter hypermethylation changes over time limit temozolomide efficacy in a phase II trial for metastatic colorectal cancer
A Amatu, L Barault, C Moutinho, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2014
Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer
J Y Douillard, S Siena, J Cassidy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 27, 2015
Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer
L Barault, A Amatu, F E Bleeker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 26, 2014
High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors: mature results of an Italian randomized phase II study
A Necchi, L Mariani, M Di Nicola, et al.
ESMO Open
|
July 16, 2025
Prognostic impact and clinical management of pT4N0 colon cancer: data from a large, multicenter, international, real-world dataset
V Daprà, A Gandini, F Schietroma, et al.
Page
of 17